FDA approves AIDS combination pill

Article

WASHINGTON (AP) - In the latest effort to trim the number of pills HIV-infected patients swallow, the government on Wednesday approved Glaxo Wellcome's Trizivir - a combination of the company's older AIDS drugs AZT, 3TC and abacavir.

Glaxo already sold AZT-3TC combination under the brand name Combivir. Adding the third drug to create Trizivir means patients could swallow two pills a day instead of the four needed for Combivir plus abacavir.

However, the three drugs are from an older family of AIDS drugs called nucleoside analogs. The most recommended AIDS therapy today is a newer drug, called a protease inhibitor, plus two nucleoside analogs.

The Food and Drug Administration issued a stern warning while approving Trizivir: About 5 percent of people who try abacavir, also known as Ziagen, suffer a serious, sometimes fatal, allergic reaction - so people trying the new Trizivir run the same risk. Do not take Trizivir if you have experienced hypersensitivity symptoms - fever, skin rash, fatigue, nausea, vomiting or trouble breathing - after taking Ziagen, FDA warned. Patients will receive a symptom warning brochure, and doctors should report hypersensitivity cases by calling 1-800-270-0425.

Glaxo said Trizivir will be available next month and cost $26.60 a day, the same price as the three drugs separately.

:

Recent Videos
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Related Content